Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002530 |
---|---|
Receipt number | R000003090 |
Scientific Title | Targeted radiotherapy for chemotherapy resistant neuroblastoma with I-131 metaiodobenzylguanidine (MIBG) |
Date of disclosure of the study information | 2009/09/18 |
Last modified on | 2019/05/20 14:58:05 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/09/18 16:32:49 | ||
2 | Update | 2014/09/22 09:50:38 | Email Address Address TEL Name of person sending information Organization Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2015/04/20 08:22:25 | UMIN ID1 |
|
4 | Update | 2015/04/20 15:51:57 | Organization1 |
|
5 | Update | 2016/09/23 15:51:14 | Name of primary person or sponsor Organization |
|
6 | Update | 2019/03/29 09:30:38 | Date of IRB Anticipated trial start date Last follow-up date |
|
7 | Update | 2019/03/29 09:31:55 | Target sample size |
|
8 | Update | 2019/04/24 17:46:59 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
9 | Update | 2019/05/20 14:58:05 | Recruitment status Other related information |